FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital. FoRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress, as a new approach in the development of targeted anticancer drugs.
Company Details
- Employees
- 34
- Founded
- 2019
- Address
- Basel, Basel 4056, Ch
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- forxtherapeutics.com
- Keywords
- Representative jobs.
- HQ
- Basel, Basel
Forx Therapeutics Questions
Forx Therapeutics's website is forxtherapeutics.com
Forx Therapeutics's LinkedIn profile is https://ch.linkedin.com/company/forx-therapeutics
Forx Therapeutics has
34 employees.
View email and phone details for 34
employees at Forx Therapeutics.
Forx Therapeutics's industry is
Biotechnology Research
Forx Therapeutics's top competitors are
Cdr-Life Inc.,
Araris Biotech Ag,
Haya Therapeutics,
Synendos Therapeutics Ag,
Nereid Therapeutics,
Monte Rosa Therapeutics,
Endogena Therapeutics, Inc.,
Tolremo Therapeutics,
Alentis Therapeutics,
Immunos Therapeutics Ag.
Forx Therapeutics's support email address is info@forxtherapeutics.com
Forx Therapeutics's categories are Biotechnology Research
Forx Therapeutics's founding year is 2019
